WH
William Hush Allan Scott
About William Hush Allan Scott
Data last updated:
William Hush Allan Scott is a Director at Mycelium Sona Biotech Private Limited (since 2021). The company operates in Life Sciences. Mycelium Sona Biotech Private Limited reported revenue of ₹1.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mycelium Sona Biotech Private Limited U01409KA2021FTC143780 | Director | 13 Aug 2021 | 2021 | ₹1.75 Cr (FY 2025) | Active |
Board colleagues of William Hush Allan Scott
| Name | DIN | Company | Designation |
|---|---|---|---|
| Donald Charles Brumley | 09258791 | Mycelium Sona Biotech Private Limited | Director |
| Muralidhar Padmanabha Rao | 03530287 | Mycelium Sona Biotech Private Limited | Director |
| Neville James Fielke | 09257130 | Mycelium Sona Biotech Private Limited | Director |
| Valliappa Chockalingam | 01753052 | Mycelium Sona Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for William Hush Allan Scott
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about William Hush Allan Scott
William Hush Allan Scott currently holds 1 directorship: Mycelium Sona Biotech Private Limited (Director, since 13 Aug 2021, revenue ₹1.75 Cr (FY 2025)).
William Hush Allan Scott was first appointed on 13 Aug 2021 as Director at Mycelium Sona Biotech Private Limited.
The current boards of William Hush Allan Scott's companies include Donald Charles Brumley (Mycelium Sona Biotech Private Limited), Muralidhar Padmanabha Rao (Mycelium Sona Biotech Private Limited), Neville James Fielke (Mycelium Sona Biotech Private Limited), Valliappa Chockalingam (Mycelium Sona Biotech Private Limited).